U S PHYSICAL THERAPY INC /NV 8K

U.S. Physical Therapy reported solid Q2 2026 revenue growth with near-flat EBITDA, driven by strong clinic volumes and expanding hospital affiliations but offset by elevated employee healthcare costs and advance hiring, while reaffirming full-year guidance and emphasizing future growth from acquisitions and hospital partnerships.

U.S. Physical Therapy, Inc. held its second quarter 2026 earnings conference call, reporting 8.5% year-over-year total revenue growth to $214 million driven by strong visit volumes and record net revenue per visit, while margins were pressured by higher self-insured employee healthcare costs and front-loaded hiring tied to hospital affiliation rollouts such as its NYU Langone and Gulf Coast partnerships. Management detailed the integration of 31 existing clinics into hospital affiliation structures in Q2, with the remaining 39 clinics expected to integrate in Q3, generating $5.6 million in Q2 revenue from hospital agreements that include per-visit fees and reimbursement of licensed staff, and positioning the company for a stronger margin profile in Q4 and into 2027 as these affiliations scale. The company also highlighted continued growth in its industrial injury prevention segment, recent and pending acquisitions including a 12-clinic PT practice acquired post-quarter for $16.4 million, expansion of its credit facility to $450 million plus a $125 million accordion to support future M&A, ongoing finance and HR systems upgrades targeted for early 2027, active share repurchases, and reaffirmed full-year 2026 adjusted EBITDA guidance of $102–$106 million, while signaling expectations for further hospital partnerships and digital/hybrid initiatives to support growth in 2027 and beyond.

Filing Facts

CIK

885978

Ticker

-

Form

8K

Source Type

sec

Accession

0000885978-26-000045

Alert Tier

7